Frontlight ResearchEarly access
Chronic kidney disease trials in Romania
9 of 14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Bucharest, Cluj-Napoca, Craiova, Oradea, Suceava, Timisoara
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - Phase 3Taking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Baia Mare, Baloteşti, Brasov, Bucharest, Iași, Maramureș, Oradea, Ploiesti, Satu Mare, Sibiu, Targu Mures, Târgu Mureş, Timisoara
- Age
- 50 years and over
- People
- 7,140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - Phase 4Taking peopleEffect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus
- Where
- Bucharest
- Age
- 18 years and over
- People
- 200
- Run by
- Anemia Working Group Romania
See details and how to joinNCT06281899 - Phase 3Not yet taking people in RomaniaA Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Where
- Brasov, Bucharest, Craiova, Galati, Oradea, Timișoara
- Age
- 18 years to 99 years
- People
- 2,800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Brasov, Bucharest, Cluj-Napoca, Constanța, Craiova, Deva, Iași, Oradea, Ploieşti, Satu Mare, Târgu Mureş
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - Phase 3Taking peopleEfepoetin alfa for treatment of anemia in chronic kidney disease on dialysis
- Where
- Bucharest, Craiova
- Age
- 18 years and over
- People
- 337 worldwide
- Run by
- Genexine Inc.
See details and how to join2023-503634-50-01 - Phase 3Not yet taking people in RomaniaA Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Where
- Brasov, Bucharest, Cluj-Napoca, Iasi, Oradea, Ploieşti, Timisoara
- Age
- 18 years and over
- People
- 7,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00 - Phase 1Not yet taking people in RomaniaA Participant- and Investigator--Blinded, Placebo-Controlled, Randomized, Multipart, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants with Chronic Kidney Disease
- Where
- Bucharest, Cluj-Napoca
- Age
- 18 years and over
- People
- 44 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-520978-18-00 - Phase 2WithdrawnSafety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
- Where
- Oradea
- People
- 28 worldwide
- Run by
- Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
See details and how to joinNCT04580420